Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04446728 · ClinicalTrials.gov registry record · NA
Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer
A NA study of Pediatric Cancer, sponsored by Nemours Children's Clinic.
- Active
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04446728: Active NA study of Pediatric Cancer, sponsored by Nemours Children's Clinic.
NCT04446728 is a NA study of Pediatric Cancer that is active but no longer recruiting, run by Nemours Children's Clinic. The registered enrollment target is 18 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04446728, a NA study of Pediatric Cancer, is active but no longer recruiting, sponsored by Nemours Children's Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The diagnosis and treatment of pediatric cancer adversely affects multiple levels of the social ecology, including patient and caregiver physical and psychosocial health. It is the strong recommendation from the first Standard of the Psychosocial Standards of Care in Pediatric Cancer that cancer centers engage in universal, systematic, psychosocial risk screening for newly diagnosed patients and their families. Universal screening at diagnosis fosters early identification of psychosocial risks and provides the opportunity to match psychosocial care to the level of family need for more equitable, effective and integrated services. However, few programs offer such care in an efficient, comprehensive, and consistent manner, potentially resulting in insufficient care that magnifies inequities in outcomes. To support pediatric cancer centers in their goal of meeting the first Standard of Psychosocial Care, this study will compare two implementation strategies for the Psychosocial Assessment Tool (PAT), a validated parent report screener of family psychosocial risk in English and Spanish, in a cluster randomized trial across 18 pediatric cancer programs in the United States.
Primary Outcome
Number of families screened divided by number of families eligible
Conditions Studied
Interventions
- BEHAVIORAL Training Webinar
- BEHAVIORAL Training Webinar Plus Implementation Enhanced Resources (TIER)
Study Locations (1)
Delaware
- Nemours Children's Health - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT04446728 still lists
NCT04446728 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 2 interventions - of which Training Webinar is the first listed.
NCT04446728 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT04446728 about?
NCT04446728 is a clinical study titled "Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer". The diagnosis and treatment of pediatric cancer adversely affects multiple levels of the social ecology, including patient and caregiver physical and psychosocial health. It is the strong recommendation from the first Standard of the Psychosocial Standards of Care in Pediatric Cancer that cancer cen...
What is the current status of trial NCT04446728?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2021-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04446728 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT04446728?
The interventions under investigation include: Training Webinar (BEHAVIORAL), Training Webinar Plus Implementation Enhanced Resources (TIER) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04446728?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04446728 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04446728's enrollment target sits among peer trials
18 43rd of 51 higher than 9 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
-
Medically Tailored Meals for Kids
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI